Crossmark

IDH1-R132 changes vary according to NPM1 and other mutations status in AML

Crossref DOI link: https://doi.org/10.1038/s41375-018-0299-2

Published Online: 2019-01-08

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Falini, Brunangelo

Spinelli, Orietta https://orcid.org/0000-0003-0374-1536
Meggendorfer, Manja

Martelli, Maria Paola

Bigerna, Barbara

Ascani, Stefano

Stein, Harald

Rambaldi, Alessandro https://orcid.org/0000-0002-3739-7502
Haferlach, Torsten
Funding

Funding for this research was provided by:

EC | European Research Council (ERC Adv Grant 2016 n. 740230)

Associazione Italiana per la Ricerca sul Cancro (AIRC IG 2016 n.18568)
License Information

Text and Data Mining valid from 2019-01-08
More Information

Article History

Received: 7 August 2018

Revised: 17 September 2018

Accepted: 26 September 2018

First Online: 8 January 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.